SLC2A1 and ovarian carcinoma: To define the role of the PI3K-AKT pathway and of the oncosuppressors p53 and PTEN in the plasmamembrane expression of GLUT1 in cancer, we have included in our study four ovarian cancer cell lines that differ for the functional expression of these proteins (Table 1).